Document Detail


The role of placental Fas ligand in maintaining immune privilege at maternal-fetal interfaces.
MedLine Citation:
PMID:  10406074     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
It is now recognized that immunosuppressive factors synthesized by placenta may play a critical role in the maintenance of pregnancy. Over the last several years our group and others have formulated a hypothesis that trophoblast Fas ligand (FasL) plays an important role in maintaining fetal immune privilege in human pregnancy by actively promoting apoptosis (programmed cell death) of activated maternal lymphocytes bearing Fas (i.e., the FasL receptor). This review initially provides background information and updates aspects of the Fas/FasL signaling system, including the role of caspases and molecules recruited to the Fasl/Fas signaling complex and the revised functions ascribed to membrane and soluble forms of FasL. Information is then presented concerning the role of FasL at immune-privileged sites including the eye and testis. Pathways through which the placenta and tumors avoid may avoid immune clearance vis-à-vis the FasL/Fas signaling cascade are described. A model is then presented through which FasL production by human syncytiotrophoblasts and extravillous trophoblasts may protect the fetus against the cytolytic actions of activated Fas-bearing maternal lymphocytes in the intervillous space and in the placental bed, respectively. We conclude with a review of studies in support this model that specifically demonstrate trophoblast expression of FasL and identify potential lymphocyte targets (i.e., Fas-expressing maternal immune cells) of trophoblast FasL.
Authors:
S Guller; L LaChapelle
Related Documents :
22281884 - The use of bisphosphonates in women prior to or during pregnancy and lactation.
3177544 - Multiple pregnancy-induced remissions of psoriatic arthritis: case report.
18056344 - Passive immunization against the mhc class i molecule mamu-ag disrupts rhesus placental...
12594944 - At the innate frontiers between mother and fetus: linking abortion with complement acti...
10438414 - Early resort to ovarian stimulation improves the cost-effectiveness of a donor insemina...
22058644 - Tamoxifen: an alternative to clomiphene in women with polycystic ovary syndrome.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in reproductive endocrinology     Volume:  17     ISSN:  0734-8630     ISO Abbreviation:  Semin. Reprod. Endocrinol.     Publication Date:  1999  
Date Detail:
Created Date:  1999-08-26     Completed Date:  1999-08-26     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8308354     Medline TA:  Semin Reprod Endocrinol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  39-44     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, New York University School of Medicine, NY 10016, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis
Fas Ligand Protein
Female
Fetus / immunology*
Humans
Immune Tolerance*
Membrane Glycoproteins / physiology*
Placenta / immunology*
Pregnancy
T-Lymphocytes
Trophoblasts / metabolism
Chemical
Reg. No./Substance:
0/FASLG protein, human; 0/Fas Ligand Protein; 0/Membrane Glycoproteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Paracrinology of endometrial neuropeptides: corticotropin-releasing hormone and opioids.
Next Document:  The decidua regulates hemostasis in human endometrium.